Outset Medical Reports New Direct Financial Obligation
Ticker: OM · Form: 8-K · Filed: Jan 2, 2024 · CIK: 1484612
| Field | Detail |
|---|---|
| Company | Outset Medical, INC. (OM) |
| Form Type | 8-K |
| Filed Date | Jan 2, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $66.5 million, $200.0 million |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: debt, financial-obligation, 8-K
TL;DR
**Outset Medical just took on a new financial obligation, watch for details on its impact.**
AI Summary
Outset Medical, Inc. filed an 8-K on January 2, 2024, to report the creation of a direct financial obligation. This filing, under Item 1.01, indicates a new financial commitment for the company. For investors, this matters because new financial obligations can impact the company's balance sheet, cash flow, and ultimately, its profitability and stock valuation, depending on the nature and size of the obligation.
Why It Matters
New financial obligations can affect a company's financial health and future flexibility, potentially impacting its ability to invest in growth or return capital to shareholders.
Risk Assessment
Risk Level: medium — The filing indicates a new financial obligation without specifying its nature or amount, creating uncertainty about its potential impact on the company's financial health.
Analyst Insight
Investors should await further disclosures to understand the nature, size, and terms of this new financial obligation to assess its potential impact on Outset Medical's financial performance and valuation.
Key Players & Entities
- Outset Medical, Inc. (company) — the registrant filing the 8-K
- January 2, 2024 (date) — date of earliest event reported and filing date
- Delaware (company) — state of incorporation for Outset Medical, Inc.
- 001-39513 (company) — Commission File Number for Outset Medical, Inc.
- OM (company) — trading symbol for Outset Medical, Inc. Common Stock
- The Nasdaq Stock Market LLC (company) — exchange where Outset Medical, Inc. Common Stock is registered
FAQ
What is the specific item number under which Outset Medical, Inc. filed this 8-K?
Outset Medical, Inc. filed this 8-K under Item 1.01, titled "Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant."
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is Outset Medical, Inc.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 2, 2024.
What is the trading symbol and the exchange where Outset Medical, Inc.'s Common Stock is registered?
Outset Medical, Inc.'s Common Stock trades under the symbol OM and is registered on The Nasdaq Stock Market LLC.
What is Outset Medical, Inc.'s business address?
Outset Medical, Inc.'s business address is 3052 Orchard Dr., San Jose, California 95134.
Filing Stats: 450 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-01-02 16:41:23
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share OM The Nasdaq S
- $66.5 million — ny) borrowed and received approximately $66.5 million term loans under its existing term loan
- $200.0 million — amount of the SLR Term Loan Facility is $200.0 million. SIGNATURES Pursuant to the require
Filing Documents
- om-20240102.htm (8-K) — 39KB
- 0000950170-24-000306.txt ( ) — 157KB
- om-20240102_lab.xml (EX-101.LAB) — 17KB
- om-20240102_pre.xml (EX-101.PRE) — 11KB
- om-20240102.xsd (EX-101.SCH) — 2KB
- om-20240102_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Outset Medical, Inc. Date: January 2, 2024 By: /s/Nabeel Ahmed Nabeel Ahmed Chief Financial Officer